Alexandros Charitou is a director in Life Sciences and the European MedTech practice leader.

With more than 20 years of experience in healthcare and life sciences, he provides expertise in strategic commercial opportunity assessments, clinical advisory, and regulatory strategy supporting both medical technology and pharmaceutical companies.

Alexandros is a subject matter expert on the new European Medical Device Regulations as well as European medical device regulatory and commercial strategy. He has a special interest in drug-device combination products and medical software.

He works closely with start-ups, medical device and pharmaceutical clients helping them with:

• Medical Technology and Pharmaceutical Due Diligence, Commercial Strategy and Brand Planning
• Clinical evidence and quality systems for CE marking of SaMDs, digital and connected health products
• European Medical Device Regulatory Affairs, MDR Transition and implementation
• CE Marking, Clinical Evaluation, Risk Assessment ISO 14971, NHS Safety Case to DCB 0129
• ISO 13485 Quality Management System design, implementation, remediation and auditing
• Application of agile methodologies in medical device manufacturing

Alexandros studied medicine at the Royal Free Hospital in London and followed on with higher surgical training in cardiothoracic and major trauma surgery. He was a cardiothoracic surgeon in the UK and clinical lead for chest trauma, responsible for developing and running the chest trauma service at one of London's major trauma centres.